Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I study.
Zhou L, Wu X, Chi Z, Si L, Sheng X, Kong Y, Mao L, Lian B, Tang B, Yan X, Wang X, Bai X, Li S, Wei X, Li J, Yang Q, Guo J, Cui C.
Zhou L, et al. Among authors: bai x.
BMC Cancer. 2022 May 20;22(1):565. doi: 10.1186/s12885-022-09663-5.
BMC Cancer. 2022.
PMID: 35596181
Free PMC article.
Clinical Trial.